Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two vs Three Cycles of Cisplatin-Based CCRT in Low-Risk Nasopharyngeal Carcinoma
NCT02871518Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cisplatin in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Progress-free survival at 3 years. Status: unknown.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02871518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02871518.